Monteiro, Rodrigo P.Calhau, Isabel B.Gomes, Ana C.Mendes, Ricardo F.Paz, Filipe A. AlmeidaD. Lopes, AndréSilva, José Paulo daRomão, Carlos C.Gonçalves, Isabel S.Pillinger, Martyn2025-04-152025-04-152025-03-260276-7333http://hdl.handle.net/10400.1/27042Iron(II) cyclopentadienyl carbonyl complexes are promising as CO-releasing molecules (CORMs) for therapeutic applications. In common with other metallodrugs, the practical application of Fe-CORMs may require their conjugation with biocompatible carriers to improve their bioavailability and protect them from premature degradation. Here, we show that the CO-releasing properties of the complexes [CpFe(CO)2Cl] (1) and [CpFe(CO)2CH2CONH2] (2) are retained when noncovalently encapsulated within cucurbit[7]uril (CB7), a well-established drug-enhancing excipient. The inclusion compounds were characterized in the solid-state by single-crystal and powder XRD, ATR-IR spectroscopy, Raman spectroscopy, TGA, and 13C{1H} CP MAS NMR. In the crystal structure of 2@CB7, there are two crystallographically independent [2@CB7] binary complexes that differ in the orientation of the guest molecules inside the CB cavity. High-resolution ESI-MS and 1H NMR studies verified the formation and stability of 1:1 2@CB7 inclusion complexes in an aqueous solution. In a physiological buffer, complex 2 is stable in the dark, but releases ca. 1.4 equiv of CO when irradiated with low-power cold white light, with a half-life (t 1/2) of 19.2 +/- 1.9 min. The photodecarbonylation behavior of the complexes is largely maintained in the inclusion compounds, with t 1/2 of 10.0 +/- 0.6 and 21.1 +/- 1.9 min for encapsulated 1 and 2.engjournal article10.1021/acs.organomet.4c004691520-6041